Physician

Christopher Bryant Kruse, M.D.

According to 2025 Medicare claims, Christopher Kruse, M.D. (NPI: 1083636898) practices micrographic dermatologic surgery in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is CHRISTOPHER B. KRUSE, M.D., LLC (NPI: 1457598112; TIN: 223799931) and primary practice location at 07701-5919.

Kruse's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 603 traditional Medicare patients, billed 2,118 HCPCS/CPT codes, and received $598,917 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 57 prescription claims across 40 beneficiaries totaling $4,576 in drug costs, led by Gentamicin Sulfate (Gentamicin Sulfate). Open Payments data shows 12 records totaling $230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,260 and ending at $4,576. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	747	2,964	$623,567
2016	701	2,693	$622,296
2017	659	2,680	$674,774
2018	756	3,162	$719,636
2019	711	3,104	$730,603
2020	659	2,449	$673,429
2021	749	2,539	$787,596
2022	672	2,143	$669,871
2023	693	2,250	$675,015
2024	603	2,118	$598,917

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	49	71	$10,260
2016	47	86	$25,104
2017	36	69	$25,631
2018	57	67	$3,685
2019	65	80	$5,525
2020	71	104	$30,840
2021	67	87	$5,430
2022	53	80	$3,173
2023	34	47	$1,638
2024	40	57	$4,576

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	420	520	$535
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	160	264	$346
13132	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm	162	177	$200
12032	Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm	102	126	$186
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	165	225	$72

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gentamicin Sulfate	Gentamicin Sulfate	23	578	$734

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$230	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Bryant Kruse, M.D.?

Tedicare shows public-source Medicare data for Christopher Bryant Kruse, M.D. (NPI 1083636898), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Bryant Kruse, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Bryant Kruse, M.D.?

Christopher Bryant Kruse, M.D. is linked to CHRISTOPHER B. KRUSE, M.D., LLC (billing NPI 1457598112) in the available physician profile data.

Does Christopher Bryant Kruse, M.D. have Open Payments data?

Christopher Bryant Kruse, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.